Oral Presentations

Session Number	Presenter	Session	Presentation title	Time	Access
OP-1	Amir Sharif	Oral Presentations	Hydrogen sulfide-based therapeutics for neurological conditions	09:29 min	View Oral Presentation
OP-2	Jendé Zijlmans	Oral Presentations	The role of cognitive and brain reserve in late-life depression	09:41 min	View Oral Presentation
OP-3	Sabah Rehman	Oral Presentations	Sex Differences in Delayed Cerebral Ischemia and Hydrocephalus after Aneurysmal Subarachnoid Haemorrhage (aSAH) - A Systematic Review and Meta-Analysis	09:38 min	View Oral Presentation
OP-4	Iago Perissinotti	Oral Presentations	Stroke etiologies in patients with COVID-19	19:18 min	View Oral Presentation
OP-5	Thuy Nguyen	Oral Presentations	Facilitators to more timely treatment following aneurysmal subarachnoid hemorrhage in Southest Australia: results from na embedded mixed-methods study	10:05 min	not available
OP-6	Gita Soraya	Oral Presentations	Significant Association between the COMT, MAO-B, and DRD2 Polymorphisms with susceptibility to Motor Levodopa-induced Complications (MLIC) in	15:38 min	View Oral Presentation
OP-7	Abolfazl Avan	Oral Presentations	Age-, sex-, and risk-specific burden of neurological diseases in the North Africa and Middle East from 1990 to 2019: A systematic analysis of data from the Global Burden of Disease Study 2019	07:58 min	View Oral Presentation
OP-8	Rita Krishnamurthi	Oral Presentations	Incidence of Stroke during the SARS-COV-2 Pandemic in New Zealand; Findings from ARCOS V, 2020	11:28 min	View Oral Presentation

Videos on Demand

Session Number	Presenter	Session	Presentation title	Time	Access
TS-1	B. Norrving	Teaching Session: Meet the Editors	Meet the Immediate Past Editor of European Stroke Journal	18:21 min	View Presentation
TS-2	V. Feigin	Teaching Session: Meet the Editors	Meet the Editor of Neuroepidemiology	20:11 min	View Presentation
P1-1	E. Westenberg	Plenary Session #1: Neurological Disorders and COVID-19	Global COVID-19 Neuro Research Coalition	08:05 min	View Presentation
P1-2	M. Giroud	Plenary Session #1: Neurological Disorders and COVID-19	Telemedicine in Neurology since the COVID-19 pandemic	12:08 min	View Presentation
P1-3	D. Gandhi	Plenary Session #1: Neurological Disorders and COVID-19	Neurological rehabilitation during the COVID-19 pandemic: What changes and what have we learnt	27:44 min	View Presentation
P1-4	T. Wijeratne	Plenary Session #1: Neurological Disorders and COVID-19	Post Covid-19 Neurological Syndrome - Current Status and Future Perspective	15:15 min	View Presentation
P1-5	D. Gandhi	Plenary Session #1: Neurological Disorders and COVID-19	Telerehabilitation for Neurological care- how real is the impact across the world- HIC versus LMIC perspectives	29:25 min	View Presentation
P1-6	V. Feigin	Plenary Session #1: Neurological Disorders and COVID-19	Primary stroke and cardiovascular disease prevention strategy needs overhaul	10:03 min	View Presentation
P2-1	M. Chun	Plenary Session #2: Application of Risk Prediction (Scores) in Neurology	What the COVID-19 crisis is telling humanity	11:04 min	View Presentation
P3-1	G. Biessels	Plenary Session #3: Neuroepidemiology of Cognition	Lesion location helps to better understand cognitive impact of cerebrovascular disease: the Mata VCI Map consortium	12:37 min	View Presentation
P3-2	A. Brodtmann	Plenary Session #3: Neuroepidemiology of Cognition	Targeting exercise to prevent vascular cognitive impairment: the Post-Ischaemic Stroke Cardiovascular Exercise Study	11:20 min	View Presentation
P3-3	S. Pendlebury	Plenary Session #3: Neuroepidemiology of Cognition	Epidemiology and novel risk factors for dementia after stroke	14:43 min	View Presentation
P3-4	C. Chen	Plenary Session #3: Neuroepidemiology of Cognition	Preventing Vascular Cognitive Impairment with multiple lifestyle interventions	15:09 min	View Presentation
P4-1	E. Harshfield	Plenary Session #4: Genetics and Application of Mendelian Randomisation in Neurology	Metabolic associations with stroke, dementia, and imaging markers of cerebral small vessel disease: a comprehensive metabolomics study	06:54 min	View Presentation
P4-2	R. Akinyemi	Plenary Session #4: Genetics and Application of Mendelian Randomisation in Neurology	Genetics of stroke in Africans	17:21 min	View Presentation
P5-1	C. Ketzoian	Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases	Multiple Sclerosis Incidence in Uruguay: A Population-based Study	14:28 min	View Presentation
P5-2	J. Correale	Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases	Barriers to access and utilization of multiple sclerosis care services in Latin American patients	20:53 min	View Presentation
P5-3	C. Ketzoian	Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases	Poverty and neurological disorders in middle-low income countries	15:39 min	View Presentation
P5-4	F. Gracia	Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases	Prevalence and incidence surveys of MS in Latin America and the Caribbean	18:11 min	View Presentation
P5-5	J. Correale	Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases	Environmental factors involved in the development of MS in Latin America	27:36 min	View Presentation
SP-1	D. Wiebers	Special session: Brain Health, One Health and COVID-19	Brain Health, One Health, COVID-19 and Our Collective Future	16:55 min	View Presentation
SP-2	M. Brainin	Special session: Brain Health, One Health and COVID-19	'Brain Health': vision or study endpoint?	24:35 min	View Presentation
SP-3	A. Winkler	Special session: Brain Health, One Health and COVID-19	Advantages of a One Health Approach For Communicable and Noncommunicable Diseases	27:34 min	View Presentation
SP-4	A. Quain	Special session: Brain Health, One Health and COVID-19	One Welfare, the Role of Health Professionals and Climate Change	21:13 min	View Presentation
SP-5	T. Wyatt	Special session: Brain Health, One Health and COVID-19	Harm, Earth Juris Prudence and Human/Nonhuman Relationships	20:12 min	View Presentation
SP-6	K. Lee	Special session: Brain Health, One Health and COVID-19	Rethinking Global Governance to Address Zoonotic Disease Risk	26:37 min	View Presentation
P6-1	M. Olaiya	Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data	Propensity score techniques	13:12 min	View Presentation
P6-2	C. Riberholt	Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data	Statistical considerations for reducing the risk of type I or II errors in systematic reviews and meta-analysis	14:32 min	View Presentation
P6-3	M. Kilkenny	Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data	Target trial approach	14:27 min	View Presentation
P6-4	D. Cadilhac	Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data	Patient reported outcomes for guiding clinical practice, comparing service performance, and clinical data interpretation	15:07 min	View Presentation
P7-1	J. Pandian	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Artificial Intelligence in stroke epidemiology	13:21 min	View Presentation
P7-2	W. Wang	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Epidemiology and community control of epilepsy in rural areas of China	15:27 min	View Presentation
P7-3	J. Chopra	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Neuropsychological rehabilitation in low resource settings - Challenges and outcomes	12:18 min	View Presentation
P7-4	J. Pandian	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Methodology for documentation of stroke deaths in LMICs: challenges and way forward	12:48 min	View Presentation
P7-5	D. Sun	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Epidemiology of brain injury	11:55 min	View Presentation
P7-6	J. Pandian	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	How to integrate stroke implementation research in health care system of developing countries	12:47 min	View Presentation
P7-7	S. Ge	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Epidemiology of stroke and TIA	14:52 min	View Presentation
P7-8	J. Chopra	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Cognitive and psychological rehabilitation in psychogenic non-epileptic seizures versus generalized epilepsy	11:42 min	View Presentation
P7-9	A. Winkler	Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC	Challenges and Opportunities of neurological research in sub-Saharan Africa	12:57 min	View Presentation
S1-1	M. Alt Murphy	Scientific Session 1: Stroke and Dementia	Upper limb sensorimotor assessment after stroke – recommendations and implementation	17:14 min	View Presentation
S1-2	P. Sachdev	Scientific Session 1: Stroke and Dementia	Cognition, function and prevalent dementia in Centenarians and Near-Centenarians: an individual participant data (IPD) meta-analysis of 18 studies	16:11 min	View Presentation
S1-3	D. Bennett	Scientific Session 1: Stroke and Dementia	MTHFR and risk of stroke, ischemic heart disease and major non-vascular diseases: a Mendelian randomization study of Chinese adults	23:19 min	View Presentation
S1-4	M. Alt Murphy	Scientific Session 1: Stroke and Dementia	Virtual Reality in stroke rehabilitation	19:53 min	View Presentation
S1-5	D. Bennett	Scientific Session 1: Stroke and Dementia	Causal associations of blood lipids with risk of ischaemic stroke and intracerebral haemorrhage	20:48 min	View Presentation
S1-6	R. Akinyemi	Scientific Session 1: Stroke and Dementia	The burden of stroke in Africa	17:47 min	View Presentation
S1-7	D. Gabriel	Scientific Session 1: Stroke and Dementia	Long-term prognosis of primary intracerebral hemorrhage in XXI century: hospital cohorts compared to population-based cohorts	10:36 min	View Presentation
S2-1	S. Martins	Scientific Session 2: Using Research to Change Stroke Policies	How to use registries and epidemiological data to change policies?	15:18 min	View Presentation
S2-2	Y. Béjot	Scientific Session 2: Using Research to Change Stroke Policies	Clinical profile gap between stroke patients included in therapeutic trials and those in real-life practice: an important issue to deal with	14:04 min	View Presentation
S2-3	O. Pontes Neto	Scientific Session 2: Using Research to Change Stroke Policies	How to translate clinical trials in national policies?	15:23 min	View Presentation
S2-4	S. Martins	Scientific Session 2: Using Research to Change Stroke Policies	The gaps and solutions for primary prevention across the globe - to show the gaps and what the countries are doing to improve	14:15 min	View Presentation
S3-1	M. Morris	Scientific Session 3: International Networks to Advance Neurological Science & Practice	The Power of Dance for Parkinson’s: Developing Global Networks	14:52 min	View Presentation
S3-2	C. Orellana	Scientific Session 3: International Networks to Advance Neurological Science & Practice	The Collaboration of Aphasia Trialists; standardizing assessments to measure aphasia rehabilitation	09:32 min	View Presentation
S3-3	R. Fox	Scientific Session 3: International Networks to Advance Neurological Science & Practice	Global Collaboration: Lessons from Multiple Sclerosis	11:21 min	View Presentation
S3-4	G. Verheyden	Scientific Session 3: International Networks to Advance Neurological Science & Practice	The International Stroke Recovery & Rehabilitation Alliance	13:16 min	View Presentation
P8-1	Y. Béjot	Plenary Session #8: Cognitive Impairment and Dementia	Stroke in patients with cognitive impairment	13:57 min	View Presentation
P8-2	R. Akinyemi	Plenary Session #8: Cognitive Impairment and Dementia	Epidemiology, profile and determinant of post - stroke vascular cognitive impairment	18:52 min	View Presentation
P8-3	O. Godefroy	Plenary Session #8: Cognitive Impairment and Dementia	Diagnosis and management of post-stroke cognitive impairment in clinical practice	16:33 min	View Presentation
P8-4	G. Logroscino	Plenary Session #8: Cognitive Impairment and Dementia	Frontiers: FTD Incidence in Europe	10:53 min	View Presentation
P8-5	S. Debette	Plenary Session #8: Cognitive Impairment and Dementia	Cerebral small vessel disease in patients with cognitive decline	17:50 min	View Presentation
P8-6	G. Logroscino	Plenary Session #8: Cognitive Impairment and Dementia	Cognitive Impairment and Hearing Loss	16:40 min	View Presentation
P8-7	D. Ding	Plenary Session #8: Cognitive Impairment and Dementia	Olfactory dysfunction and risk of cognitive decline among older adults	20:05 min	View Presentation
P9-1	T. Wijeratne	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	Headache in ED	11:30 min	View Presentation
P9-2	T. O´Brien	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	Sudden onset death in epilepsy (SUDEP): Can it be prevented?	17:19 min	View Presentation
P9-3	G. Logroscino	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	Psychotic and Behavioral Symptoms in neurodegenerative diseases	14:42 min	View Presentation
P9-4	J. Wanigasinghe	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	Epidemiology of epilepsy in the South East Asian region	14:32 min	View Presentation
P9-5	T. Wijeratne	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	The Success story of World Brain Day	16:30 min	View Presentation
P9-6	J. Hinman	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	Antecedent autoimmune conditions and amyotrophic lateral sclerosis	12:48 min	View Presentation
P9-7	E. Zimmer	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	New perspectives in research for Alzheimer Disease	15:38 min	View Presentation
P9-8	L. Nelson	Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches	Diabetes, Diabetes Medications and the Risk of Developing ALS	14:42 min	View Presentation

Videos on Demand

Session Number	Presenter	Session	Presentation title	Time	Access
T1-1	D. Ding	Teaching Session #1: Basics of clinical neuroepidemiology (observational studies)	Aims, design and pitfalls of cross-sectional studies: Application of cross-sectional design in large-sampled multicentered population-based surveys	18:55 min	View Session
T1-2	X. Leng	Teaching Session #1: Basics of clinical neuroepidemiology (observational studies)	Writing a scientific paper and reporting an observational study	21:22 min	View Session
T1-3	Y. Pan	Teaching Session #1: Basics of clinical neuroepidemiology (observational studies)	Aims, design and pitfalls of cohort studies	12:38 min	View Session
T2-1	D. Bennett	Teaching Session #2: Basics of clinical epidemiology	Basics of biostatistics	24:17 min	View Session
T2-2	G. Logroscino	Teaching Session #2: Basics of clinical epidemiology	Type, design and pitfalls of rcts and meta-analysis	22:45 min	View Session
T2-3	D. Bennett	Teaching Session #2: Basics of clinical epidemiology	Guidelines for reporting neuroepidemiological studies	18:27 min	View Session
T3-1	D. Bennett	Teaching Session #3: Basics of clinical epidemiology (continued)	Strengths and limitations of statistical analyses	28:20 min	View Session
T3-2	G. Logroscino	Teaching Session #3: Basics of clinical epidemiology (continued)	Studies and methods for descriptive epidemiology of rare neurodegenerative diseases in population studies	18:59 min	View Session
ME-1	B. Norrving	Meet the Editors	Publishing your manuscript: My best advice	28:10 min	View Session
ME-2	V. Feigin	Meet the Editors	Neuroepidemiology: Hints for publication	29:16 min	View Session
P1-W	V. Feigin	Global impact of COVID	Welcome Message from the Chair	03:21 min	View Session
P1-1	D. Wiebers	Global impact of COVID	What the COVID-19 crisis is telling humanity (keynote lecture)	15:18 min	View Session
P1-2	E. Beghi	Global impact of COVID	Impact of COVID-19 on neurological disorders	08:03 min	View Session
P1-3	L. Liu	Global impact of COVID	Impact of COVID-19 on stroke care in China	11:00 min	View Session
P2-1	M. Owolabi	Stroke prevention and policy implications	The Lancet Neurology Commission on stroke: Evidence-based pragmatic solution to reduce the global burden of stroke (keynote lecture)	11:07 min	View Session
P2-2	G. Mensah	Stroke prevention and policy implications	Data science advances in the global prevention and treatment of stroke	11:29 min	View Session
P2-3	B. Norrving	Stroke prevention and policy implications	Using stroke statistics for policy purposes - challenges and opportunities	10:16 min	View Session
P2-4	V. Feigin	Stroke prevention and policy implications	Practical solution for motivational mass stroke prevention	10:25 min	View Session
P2-5	A. Towfighi	Stroke prevention and policy implications	From evidence to practice: What are we doing wrong?	10:21 min	View Session
P3-1	R. Krishnamurthi	Updates on and breaking news in clinical trials on stroke and dementia	Health & Wellness Coaching for primary stroke prevention: PREVENTS trial (keynote lecture)	12:58 min	View Session
P3-2	Y. Teuschl	Updates on and breaking news in clinical trials on stroke and dementia	The effects of the polypill in primary stroke prevention	09:47 min	View Session
P3-3	S. Davis	Updates on and breaking news in clinical trials on stroke and dementia	Endovascular thrombectomy - the challenges	10:33 min	View Session
P3-4	M. Brainin	Updates on and breaking news in clinical trials on stroke and dementia	Cognitive post-stroke disturbance (keynote lecture)	16:00 min	View Session
P3-5	J. Pandian	Updates on and breaking news in clinical trials on stroke and dementia	Community health workers for stroke prevention. What is the evidence?	13:38 min	View Session
P3-6	P. Sachdev	Updates on and breaking news in clinical trials on stroke and dementia	New consortia for studying dementia (COSMIC, STROKOG, and ICC) (keynote lecture)	14:17 min	View Session
P3-7	A. Ikram	Updates on and breaking news in clinical trials on stroke and dementia	Updates on dementia incidence, prevalence and risk factors in Europe	14:40 min	View Session
P3-8	R. Azarpazhooh	Updates on and breaking news in clinical trials on stroke and dementia	Why dementia incidence rates are declining	09:33 min	View Session
P4-1	T. Vos	Neuroepidemiology and Biomarkers of movement disorders	Global Burden of Neurological disorders	11:08 min	View Session
P4-2	M. Dichgans	Neuroepidemiology and Biomarkers of movement disorders	Updates on genetics in stroke risk	10:13 min	View Session
P4-3	C. Ketzoian	Neuroepidemiology and Biomarkers of movement disorders	Neuroepidemiology in Latin America	09:41 min	View Session
P4-4	Y. Béjot	Neuroepidemiology and Biomarkers of movement disorders	Impact of the ageing population on the contemporary profile of stroke patients: lessons from population-based registries	08:33 min	View Session
P4-5	B. Sabayan	Neuroepidemiology and Biomarkers of movement disorders	Heart-brain axis and brain health	11:14 min	View Session
P4-6	B. Miller	Neuroepidemiology and Biomarkers of movement disorders	Frontotemporal dementia	18:48 min	View Session
P4-7	H. Zetterberg	Neuroepidemiology and Biomarkers of movement disorders	Update on fluid biomarkers for Alzheimer's disease	15:06 min	View Session
P5-1	W. Carroll	Neurological care and rehabilitation (1)	Barriers to neurological care: Addressing the needs (keynote lecture)	13:23 min	View Session
P5-2	J. Bernhardt	Neurological care and rehabilitation (1)	Updates on post-stroke rehabilitation	09:51 min	View Session
P5-3	M. Alt Murphy	Neurological care and rehabilitation (1)	Predictors of stroke recovery	07:47 min	View Session
P5-4	A. Bonkhoff	Neurological care and rehabilitation (1)	Brain connectivity and recovery	08:33 min	View Session
P5-5	A. Thift	Neurological care and rehabilitation (1)	"They’ve got a bit better and they’re good enough to go back…” perspectives on stroke rehabilitation for aboriginal survivors	07:36 min	View Session
P6-1	W. Wang	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	Epidemiology of stroke in China (keynote lecture)	12:47 min	View Session
P6-2	P. Sachdev	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	The epidemiology of neurocognitive disorders from around the globe: findings from the COSMIC collaboration	12:47 min	View Session
P6-3	G. Deuschl	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	Changes in the epidemiology of neurological disorders in Europe	11:14 min	View Session
P6-4	T. Wijeratne	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	Increased global burden of headaches	25:14 min	View Session
P6-5	M. Hittle	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	Neurocoach - A Virtual Therapist for Post-Stroke Recovery	09:50 min	View Session
P6-6	M. Giroud	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	Psychosocial factors and stroke	07:50 min	View Session
P6-7	D. Cadilhac	Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders	10 years of the Australian Stroke Clinical Registry: How the data have been used to inform policy and practice?	10:59 min	View Session
S1-1	A. Gabet	Scientific Session #1	Impact of the COVID-19 pandemic and a national lockdown on hospitalization for stroke and related 30-day mortality in France: a nationwide observational study	14:32 min	View Session
S1-2	A. Gabet	Scientific Session #1	Characteristics, management and in-hospital mortality of patients hospitalized for stroke with a concomitant diagnostic of COVID-19 in France	09:54 min	View Session
S1-3	N. De Jong	Scientific Session #1	White matter network structure as a substrate of cognitive brain reserve in cerebral small vessel disease: the maastricht study	09:53 min	View Session
S1-4	M. Vergonjeanne	Scientific Session #1	Epidemiology of epilepsy in low- and middle-income countries: experience of a standardized questionnaire over the past two decades	08:29 min	View Session
S1-5	L. Duffner	Scientific Session #1	Can engagement in socially and cognitively stimulating leisure activities compensate for other dementia risk factors? A prospective cohort study	08:47 min	View Session
S2-1	O. Filipets	Scientific Session #2	Incidence of stroke in the urban area of western ukraine: temporal trends and features of statistical accounting	11:03 min	View Session
S2-2	R. S. Ragavan	Scientific Session #2	Impact of varying look-back periods on estimating the number of person-based first-ever occurrences of strokes using linked hospitalisation data	08:13 min	View Session
S2-3	K. Robinson	Scientific Session #2	Long-term risk of stroke in 123, 696 people with existing cardiac disease: a study using data linkage	10:17 min	View Session
S2-4	Z. Orman	Scientific Session #2	Quality of life after stroke in a cluster randomized trial. Findings from standfirm	07:23 min	View Session
S3-1	T. Ullberg, K. Månsson	Scientific Session #3	Structured multimodal follow-up after stroke: implementation aspects of a new paradigm	11:11 min	View Session
S3-2	M. Kilkenny	Scientific Session #3	Australian Stroke Data Linkage Program: Using data to improve outcomes	08:55 min	View Session
S3-3	T. Green	Scientific Session #3	Disorders of Consciousness (doc): Implications for nursing along the continuum	26:06 min	View Session
S3-4	N. Okubadejo	Scientific Session #3	Utilizing disease registries to scale up neurology research in Africa: Experience from the Nigeria Parkinson Disease Registry	09:17 min	View Session
S3-5	M. Olaiya	Scientific Session #3	Disparities by diabetes status in the quality of care and long-term outcomes following acute stroke or transient ischaemic attack	07:14 min	View Session
S3-6	S. Gall	Scientific Session #3	Evaluating the effect of personalised knowledge to reduce the risk of stroke (PERKS-International) – study design protocol	07:35 min	View Session
S4-1	A. Eliakundu	Scientific Session #4	Paramedic identification of stroke and associated access to reperfusion therapy: preliminary analysis of state linkage study	07:59 min	View Session
S4-2	A. Bonkhoff	Scientific Session #4	Enhanced efficacy of acute intra-arterial recanalization therapies in female stroke patients	09:37 min	View Session
S4-3	E. Camerucci	Scientific Session #4	Sex differences in deep brain stimulation implants, management and levodopa adjustments in two population-based parkinsonism cohorts in minnesota	06:26 min	View Session
S4-4	E. Camerucci	Scientific Session #4	Incidence and Prevalence of Motor Fluctuations and Deep Brain Stimulation in Parkinson’s disease: A Comparison Between Two Population-based Cohorts in South East Minnesota	07:19 min	View Session
S4-5	A. Stang	Scientific Session #4	Timeline, Incidence, Frequency and Survival of REM Sleep Behavior Disorder in Overt Alpha-Synucleinopathies	06:36 min	View Session
S4-6	E. Camerucci	Scientific Session #4	Early-onset parkinsonism and early-onset parkinson’s disease: a population-based study (2010-2015)	05:10 min	View Session
S5-1	L. Harvey	Scientific Session #5: Neurological care and rehabilitation (2)	Spinal cord injury rehabilitation education on a global scale (keynote lecture)	14:37 min	View Session
S5-2	D. Gandhi	Scientific Session #5: Neurological care and rehabilitation (2)	Spinal cord injury rehabilitation education on a global scale (keynote lecture)	16:21 min	View Session
S5-3	J. Marshall	Scientific Session #5: Neurological care and rehabilitation (2)	Virtual reality in aphasia rehabilitation: Applications of EVA Park	09:06 min	View Session
S5-4	C. Riberholt	Scientific Session #5: Neurological care and rehabilitation (2)	Early rehabilitation approaches in severe acquired brain injury	10:14 min	View Session
S6-1	Y. Cao	Scientific Session #6	Diet quality over middle adulthood and late-life subjective cognitive function among u.s. women	07:18 min	View Session
S6-2	R. S. Ragavan	Scientific Session #6	Effect of varying look-back periods on estimating the trends in the incidence of stroke over time, using linked hospitalisation data	07:05 min	View Session
S6-3	X. Tian	Scientific Session #6	Associations of hematological and biochemical markers with intracranial atherosclerosis: a systematic review and meta-analysis of observational studies	08:41 min	View Session
S6-4	J. Aked	Scientific Session #6	Survival, Functional Status and Recurrence Three Years After First-Ever Stroke in Southern Sweden	09:40 min	View Session
S6-5	K. Dokova	Scientific Session #6	Population-based stroke registry in varna, Bulgaria: feasibility and pilot data	08:23 min	View Session
S6-6	A. Avan	Scientific Session #6	Stroke and dementia, leading causes of neurological disability and death, potential for prevention	05:50 min	View Session
S6-7	E. Pupillo	Scientific Session #6	Early onset and increased risk of als in italian professional soccer teams	07:44 min	View Session
S7-1	S. Chopra	Scientific Session #7	Neuropsychological Rehabilitation after Traumatic Brain Injury in Low-Resource Settings – A Single Blind Randomized Study	12:50 min	View Session
S7-2	R. M. Jose	Scientific Session #7	Recurrent stroke in patients with atrial fibrillation: frequency and heterogeneity.	05:56 min	View Session
S7-3	D. Panov	Scientific Session #7	Job stress and risk of stroke in population 25-64 years in Russia/Siberia: gender issues. MONICA-psychosocial epidemiological study	06:42 min	View Session
S7-4	A. Gbessemehlan	Scientific Session #7	Association between depression, anxiety and dementia among older people in Central Africa: EPIDEMCA population-based study.	06:48 min	View Session
S7-5	S. Sardesai	Scientific Session #7	Do dynamometric grip and pinch strengths correlate with upper limb capacity measured using action research arm test in stroke survivors?	04:25 min	View Session
S7-6	A. K. Malaha	Scientific Session #7	Costs of dementia in low and middle income countries: a systematic review	06:09 min	View Session
S8-1	A. Wiśniewski	Scientific Session #8	Validation of the National Institutes of Health Stroke Scale emphasizes its moderate psychometric properties	09:55 min	View Session
S8-2	S. A. Mioramalala	Scientific Session #8	Availability and cost of antiepileptic and psychotropic drugs after community-based interventions in Madagascar	07:09 min	View Session
S8-3	L. Chen	Scientific Session #8	Trends in clinical features and risk factors of amyotrophic lateral sclerosis: A 14-year cohort study in China	07:06 min	View Session
S8-4	X. Chen	Scientific Session #8	Plasma Folate Levels in Relation to Cognitive Function: A community-based cohort of older adults in China	06:31 min	View Session
S8-5	M. Vergonjeanne	Scientific Session #8	Instruments for investigation of epilepsy in low- and middle- income countries: a systematic review	06:22 min	View Session
S8-6	S.C.O. Martins	Scientific Session #8	Adressing Lifestyle Modefication and Primary Prevention in a Continental Country	08:41 min	View Session
S8-7	A. Towfighi	Scientific Session #8	Adressing Lifestyle for Stroke Prevention	06:57 min	View Session
E	V. Feigin	Closing remarks, Best Abstract Award	Closing remarks, Best Abstract Award	03:21 min	View Session

Eposter Library

Eposter N.	Poster Titel	Main Author	Co-Authors
P1	Feasibility of Dementia Assessments in the New Zealand (NZ) Indian Community	Rita Krishnamurthi	Adrian Martinez-Ruiz, Susan Yates, Ekta Singh Dahiya, Sanjalin Naiker, Reshmi Bala, Sarah Cullum,
P2	A QUALITATIVE STUDY OF FACTORS AFFECTING TIME TO TREATMENT OF ANEURYSMAL SUBARACHNOID HAEMORRHAGE – THE REDDISH STUDY	Thuy Phuong Nguyen	C. Stirling, G. Kitsos, L. Nichols, R. Chandra, S. Rehman, K. Smith, I. Mosley, L. Lai, H. Asadi, J. Froelich, N. Thani, A. Thrift, S. Gall
P3	Comorbidities in patients with epilepsy: frequency, mechanisms and effects on long-term outcome	Giorgia Giussani	Elisa Bianchi MSc1, Simone Beretta MD PhD2, Davide Carone MD2, Jacopo C DiFrancesco MD PhD2, Andrea Stabile MD2, Clara Zanchi MD2, Marta Pirovano MD2, Claudia Trentini MD2, Giada Padovano MD2, Matteo Colombo MD2, Diletta Cereda MD2, Lorenzo Tinti MD2, Sofia Scanziani MD2, Sara Gasparini MD3, Graziella Bogliun MD2, Carlo Ferrarese MD PhD2, Ettore Beghi MD1*; for the PRO-LONG Study Group (#).
P4	Stroke Mortality Trend in Uruguay: A 60 years National Study	Stephanie Pino	Pino S, Rada D, Hackembruch H, Vázquez C, Ketzoina C, Gaye Saavedra A.
P5	Acute Triage of Pediatric Stroke in Eastern Denmark	Julie Bindslev	Klaus Hansen, Christina Hoei-Hansen, Thomas Truelsen
P6	Cerebral infarction in young adults. Analysis of 104 cases.	Otto Jesus Hernandez Fustes	M.S. Kawasaki, C. Arteaga Rodriguez
P7	Stroke subtypes in cancer patients and contributing risk factors in the stroke underlying mechanism, a retrospective study	lama almubarak	Farah Aleisa, MD, FRCPC, Hanouf Samadani, RN
P8	Excess Mortality in Stroke Patients Aged 80+ Years Receiving Acute Endovascular Recanalization Therapy, Eastern Denmark 2017-2019	Nicolaj Grønbæk Laugesen	NG. Laugesen, K. Hansen, T. Stavngaard, J. Højgaard, T. Truelsen
P9	Electrode Optimization for Home-Based Health Monitoring EEG Acquisition	Theeban Shivaraja	Wan Asyraf Wan Zaid, Noorfazila Kamal, Kalaivani Chellappan
P10	Migraine: A Cross-sectional Study among Physicians and Medical Students Regarding Prevalence, Awareness and Knowledge of Diagnosis and Management	Hassan Choudry	F. Ata, M. Suheb, N. Alam
P11	A CLUSTER-RANDOMISED CONTROLLED TRIAL EVALUATING THE EFFECTIVENESS OF STROKE RISKOMETER IN IMPROVING STROKE RISK AWARENESS IN ADULTS: A PRELIMINARY STUDY	Mohamad Zarudin Mat Said	Zarudin MS, Kamarul Imran Musa, T.Alina T.Ismail, Anees AH, Ramesh Sahathevan, Zariah AA, Valery Feigin
P12	Validation of the Lebanese Arabic version of the BACS scale (the Brief Assessment of Cognition in Schizophrenia) among schizophrenic inpatients	Chadia Haddad	Chadia Haddad, P. Salameh, S. Hallit, S. Obeid, G. Haddad, JP. Clément, B. Calvet
P13	Pontine Infarct with uncrossed Hemiparesis . A case report	Ahmed ZAMIR	Dr Naveed Alam
P14	STROKE INCIDENCE IN SARS-COVID EPIDEMICS: THE EXPERIENCE OF ODESSA	Yurii Vorokhta	Muratova T., Khramtsov D., Stoyanov A., Zbrozhek S., Voronina R., Khubetova I., Vikarenko M., Kozlova G., Dobush I., Andryuschenko E.
P15	Epidemiology of Parkinson disease in Odessa (2017-2019)	Yurii Vorokhta	I. Khubetova
P16	Evaluating the potential of mobile phone-based applications in improving stroke awareness among the Auckland Population	navneet kaur
P17	Population-based validation of prehospital stroke scales for the detection of large vessel occlusion : Dijon Stroke Registry	Gauthier Duloquin	G. Duloquin, M. Graber, L. Garnier, V. Crespy, M. Giroud, Y. Bejot
P19	INCIDENCE AND CSF BIOMARKERS PATTERN IN FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) IN THE SALENTO AREA PUGLIA	Chiara Zecca	Chiara Zecca, Maria Teresa Dell’Abate, Miriam Accogli, Rosa Capozzo, Maria Rosaria Barulli, Maria Elisa Frisullo, Giancarlo Logroscino
P20	ASSOCIATION OF ANKLE-BRACHIAL INDEX WITH ISCHEMIC STROKE OUTCOME IN DIABETIC PATIENTS: A CASE-CONTROL STUDY	Fakhrur Razy	Fakhrurrazy, S. Manurung, A. Yuwono, H. Khatimah
P21	Synergies TO Prevent stroke – STOPstroke – an interdisciplinary research program on stroke prevention	Seana Gall	Amanda Thrift, Judith Katzenellenbogen, Mark Nelson, Timothy Kleinig, Valery Feigin, Dominique Cadilhac, Lee Nedkoff, Joosup Kim, Monique Kilkenny
P23	Incidence and Prevalence of Stroke and its Risk Factors in the Philippines: A Systematic Review	Maria Epifania Collantes	Zuniga YH, Uezono DR
P24	LOW VERSUS STANDARD DOSE OF INTRAVENOUS THROMBOLYSIS WITH ALTEPLASE IN ISCHEMIC STROKE PATIENTS OLDER THAN 80 YEARS OLD: AN OBSERVATIONAL STUDY	Laura Baptiste	S. Olindon, I. Sibon, Y. Béjot
P25	Paradoxical effect of smoking on motor progression and dopaminergic putaminal denervation in Parkinson’s disease.	Daniele Urso	B. Tafuri, S. Nigro, G. Logroscino
P26	Reduction in Acute Stroke Admissions During the COVID-19 Pandemic – Data from the Israeli National Stroke Registry	Inbar Zucker	A. Ram, Y. Hershkovitz, D. Tanne, N. M. Bornstein, R. R. Leker, A. Horev, H. Hallevi, S. Peretz, D. Orion, I. Zucker
P27	Synergies TO Prevent stroke – STOPstroke – an interdisciplinary research program on stroke prevention	Seana Gall	Amanda Thrift, Judith Katzenellenbogen, Mark Nelson, Timothy Kleinig, Valery Feigin, Dominique Cadilhac, Lee Nedkoff, Joosup Kim, Monique Kilkenny
P28	Application of motor learning principles in upper limb task-oriented training in stroke clinical trials – A scoping review	Subramanian Durairaj	Sanjukta Sardesai, Dr. Mindy F. Levin, Dr. John M. Solomon

Programme Day 2

[pdfjs-viewer url=”https://access.ianeneurology.org/download/day2.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]

Programme Day 1

[pdfjs-viewer url=”https://access.ianeneurology.org/download/day1.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]

Programme Day 3

[pdfjs-viewer url=”https%3A%2F%2Faccess.ianeneurology.org%2Fwp-content%2Fuploads%2F2021%2F01%2Ftelemed_Terms-of-Use_V1.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]

UMSA

Concept

Mobility has become one of the key issues in society today. Environmental problems and pandemic effects lead to changes in transportation, the quality of life in urban communities, and the development of urban clusters. At the same time, the ageing challenge triggers a profound impact on the social fabric of cities.

By 2030 all major urban centres in the OECD will see a sharp increase in the number of elderly – the share of aged 60 and above will grow from 30% to 39%. For the first time in history, the elderly will be the largest age group by 2045.

The global ageing of urban populations calls for more age-friendly approaches to be implemented. Cities will need to adapt and develop a number of short and longer-term strategies, integrating assistive technologies, to ensure they respond adequately to both the challenges and opportunities that an ageing population present.

All these challenges affect government and community engagement, and additionally the huge universe of R&D, innovation, business and corporate solutions linked to it.

UMSA Library

Number 1	Title	Action
1	What us UMSA about ?	Click to open
2	Blog UMSA	Click to open

Contact our speakers

Library2demo

Number 1	Title	Action
1	What us UMSA about ?	Click to open
2	Blog UMSA	Click to open

PAFSSH

European Menopause and Andropause Socety
Rue du Rhone, 118
CH-1204 Geneva
Phone: +41 22 510 1278
Email: info@emas-online.org

Library

Sr.no	Title	Action
1	Company Video	Click to open
2	Pdf	Click to open

Contact

Exhibitor sample

[evp_embed_video url="https://vimeo.com/272444763" autoplay="true"]

1:1 meeting scheduling

Channel 1

Video	Slido
https://access.ianeneurology.org/wp-content/uploads/2020/08/Copy-of-Copy-of-Copy-of-pan-arb-2.png https://streaming.salesbridges.com:5443/LiveApp/streams/669185674250831530552500.m3u8

Video

Slido

https://access.ianeneurology.org/wp-content/uploads/2020/08/Copy-of-Copy-of-Copy-of-pan-arb-2.png

https://streaming.salesbridges.com:5443/LiveApp/streams/669185674250831530552500.m3u8

Rate

Please give a rate

Comments to author

Rating

Please give a rate

Exhibitor sample

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Dr. Begoña Bermejo

Physician and medical doctor from the University of Cadiz. Medical oncologist at the Clinical University Hospital of Valencia and Biomedical Research institute INCLIVA
Associate Professor of Medicine School at University of Valencia

She develops her assistance and research work in the breast pathology unit. She has an extensive experience in clinical trials and research projects in the area of breast cancer.Member of the breast cancer research group at the Carlos III institute.Member of the board of GEICAM (Spanish Breast Cancer Research Group)

Dr. Enrique Santas Olmeda

Dr. Enrique Santas, MD, PhD, is a cardiologist at the Hospital Clínico Universitario in Valencia (Spain). He is an active clinician and an emergent researcher, with a focus on heart failure and cardiac imaging. Currently, he is the director of the cardio-oncology program at his institution, dedicated to the cardiovascular health of patients undergoing cancer treatment as well as cancer survivors.

Join a meeting